Featured Research

from universities, journals, and other organizations

Rutgers Researchers Offer New Insights Into Protein Implicated In Osteoporosis Cause And Cancer Spread

Date:
July 6, 1999
Source:
Rutgers, The State University Of New Jersey
Summary:
Rutgers researchers and international colleagues develop new information on the role of the Osteopontin protein (currently under study for its role in metastatic cancer) in osteoporosis.

NEW BRUNSWICK/PISCATAWAY, N.J. -- Rutgers researchers David T. Denhardt and Susan R. Rittling, together with Hiroyuki Yoshitake and Masaki Noda of Tokyo Medical and Dental University, have announced new findings about a protein implicated in osteoporosis and metastatic cancer in the July 6 issue of the Proceedings of the National Academy of Sciences (PNAS).

Related Articles


Osteoporosis, one of the most common diseases affecting postmenopausal women, is a condition characterized by the progressive loss of bone density and thinning of bone tissue, resulting in increased fractures and diminished quality of life. In the United States, the number of patients is estimated at 12 million with an associated medical cost of about $1.2 billion.

The research explored the role of osteopontin (OPN), a protein produced by bone cells and regarded as functionally important in the regulation of bone metabolism. OPN is not required for normal bone development, but is required for certain types of bone remodeling and it strengthens the defenses of the body against certain forms of infection and injury. Considerable evidence also suggests that it facilitates the growth and spread (metastasis) of cancer cells. For this study, research methodology was designed to define more precisely the function of OPN and examine its effects on the onset of the bone resorption associated with osteoporosis.

"Susan Rittling, one of the co-authors and a research assistant professor at Rutgers, together with her colleagues developed a genetically altered strain of mice that lack the ability to produce OPN," said Denhardt, professor of cell biology and neuroscience with the Faculty of Arts and Sciences-New Brunswick. "Dr. Noda's group surgically removed the ovaries from mice of this strain to simulate the fall-off of estrogen production in postmenopausal women when their ovarian function decreases. When compared with a series of various control samples, we found that mice lacking OPN were significantly more resistant to the bone loss that accompanies estrogen depletion."

While no information exists regarding OPN deficiency in humans, the investigations of the Rutgers scientists and their colleagues present a compelling argument that some postmenopausal women might be expected to show enhanced resistance to osteoporosis because they possess an altered form of OPN.

"We propose that OPN is essential for postmenopausal osteoporosis," state the researchers in the PNAS paper. "Strategies to counteract OPN's action may prove effective in suppressing osteoporosis. Genetic analyses may predict certain patients who could have high or low risk of postmenopausal bone loss. New approaches would be available for the development of anti-bone-resorptive drugs, particularly those designed to suppress the action of OPN."

It follows that if the role of OPN in increasing cancer metastasis can be fully delineated, another subject under investigation by Denhardt and his laboratory group, the strategies to control the action of OPN will have implications for the treatment of cancer, as well.

Copies of the paper ("Osteopontin-Deficient Mice are Resistant to Ovariectomy-Induced Bone Resorption") are available to reporters from the PNAS news office by calling (202) 334-2138 or by e-mailing pnasnews@nas.edu.

NOTE TO REPORTERS/EDITORS: Additional information on David T. Denhardt's laboratory and its research can also be obtained at http:\\lifesci.rutgers.edu/~denhardt/webpage.htm. He may also be reached for interviews by calling (732) 445-4569.


Story Source:

The above story is based on materials provided by Rutgers, The State University Of New Jersey. Note: Materials may be edited for content and length.


Cite This Page:

Rutgers, The State University Of New Jersey. "Rutgers Researchers Offer New Insights Into Protein Implicated In Osteoporosis Cause And Cancer Spread." ScienceDaily. ScienceDaily, 6 July 1999. <www.sciencedaily.com/releases/1999/06/990630104148.htm>.
Rutgers, The State University Of New Jersey. (1999, July 6). Rutgers Researchers Offer New Insights Into Protein Implicated In Osteoporosis Cause And Cancer Spread. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/1999/06/990630104148.htm
Rutgers, The State University Of New Jersey. "Rutgers Researchers Offer New Insights Into Protein Implicated In Osteoporosis Cause And Cancer Spread." ScienceDaily. www.sciencedaily.com/releases/1999/06/990630104148.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins